Noda Aoi, Obara Taku, Satoh Michihiro, Yagi Naoto, Mano Nariyasu, Kaneko Kenji
J Pediatr Pharmacol Ther. 2021;26(4):352-360. doi: 10.5863/1551-6776-26.4.352. Epub 2021 May 19.
Safety information regarding the use of medication, over-the-counter drugs, and supplements for Japanese children is scarce. The aim of this study was to clarify adverse drug reaction (ADR) experiences in children and consider the method to collect ADRs efficiently.
We conducted a questionnaire survey regarding the ADR experiences of 20,412 children who were attending a preschool or kindergarten in the cities of Warabi and Toda, Saitama Prefecture, in May 2013.
Responses were received from the guardians of 15,076 children (49.5% girls; 8.2 ± 3.5 yr). A total of 196 guardians (1.3%) responded that their children had experienced ADRs. Among them, a total of 243 suspected drugs and 284 ADRs were reported. Of the 243 suspected drugs, 2.5% were associated with a vaccine. The most frequently reported medication, reaction, and "medication-reaction pair" were antibacterials for systemic use, rash, and "antibacterials for systemic use and rash," respectively.
In this study, we clarified that there were many potential ADRs among children, but all "medication-reaction pairs" reported were consistent with adverse events reported in the clinical trials available in the prescribing information of each medication. This study provides data respective to the frequency of these adverse events in the general pediatric population. Additional education is needed to enlighten guardians of the importance to report ADRs through the Direct Patient Reporting System.
关于日本儿童使用药物、非处方药和补充剂的安全信息匮乏。本研究的目的是阐明儿童的药物不良反应(ADR)经历,并考虑有效收集ADR的方法。
2013年5月,我们对埼玉县蕨市和户田市的20412名学龄前儿童或幼儿园儿童的ADR经历进行了问卷调查。
收到了15076名儿童监护人的回复(女孩占49.5%;年龄8.2±3.5岁)。共有196名监护人(1.3%)回复称他们的孩子经历过ADR。其中,共报告了243种可疑药物和284例ADR。在243种可疑药物中,2.5%与疫苗有关。报告最多的药物、反应和“药物-反应对”分别是全身用抗菌药物、皮疹和“全身用抗菌药物和皮疹”。
在本研究中,我们阐明儿童中存在许多潜在的ADR,但所有报告的“药物-反应对”均与每种药物处方信息中临床试验报告的不良事件一致。本研究提供了一般儿科人群中这些不良事件发生频率的数据。需要进一步开展教育,让监护人了解通过直接患者报告系统报告ADR的重要性。